Catherine Price, MD, ECNU, FACE retweeted
Congratulations to all who matched!! We’re so excited for our next intern class! #Match2025
Help support my ride for a cure @Advocacy_ADA tour.diabetes.org/index.cfm?…
Gratitude for working with such awesome humans at an amazing conference on Belonging in Healthcare @wakeforestmed @AtriumHealthWFB @advocatehealth #WakeEndo
Catherine Price, MD, ECNU, FACE retweeted
Join the ADA on Feb 20, 4:00 PM ET & Learn how to interpret CGM data, optimize treatment plans, & master documentation & billing from experts Catherine Price, MD, ECNU, FACE @Wake_Endocrine, Carrie Keyes, PA-C, & Anyanate Gwendolyne Jack, MD. Register here bit.ly/3WG9S59
Looking forward to this opportunity to educate others on utilization of CGM data
Join the ADA on Feb 20, 4:00 PM ET & Learn how to interpret CGM data, optimize treatment plans, & master documentation & billing from experts Catherine Price, MD, ECNU, FACE @Wake_Endocrine, Carrie Keyes, PA-C, & Anyanate Gwendolyne Jack, MD. Register here bit.ly/3WG9S59
Catherine Price, MD, ECNU, FACE retweeted
Barriers to insulin-treated #type2diabetes management using #CGM in UK primary care identified:
🔹 Resistance to change among care teams 🛑
🔸 Limited experience with CGM devices 📉
🔹 Concerns over inconsistent CGM guidelines 📃
🧑⚕️ Education and workflow updates critical for CGM adoption. 💡
🔗ggdocs.co/x0d495
Excellent update on clinically high impact areas of Endocrinology given today for the biannual update by @miya_mck and @Usoh_Endocrine @wakeforestmed @AtriumHealthWFB #WakeEndo
Hot off the press: block and replace strategy for management of hypercortisolism in patient with metastatic adrenal cortical carcinoma @wakeforestmed @AtriumHealthWFB sciencedirect.com/science/ar…
Catherine Price, MD, ECNU, FACE retweeted
Get ready for our upcoming webinar on #MASLD / #MASH management! On Nov 20, @JonathanStineMD, Kerry Sivia, & Dr. @Shelley_Keating discuss the impact of exercise & lifestyle changes on liver health & share real-life experiences in managing the disease. bit.ly/3XYvb1B
Excellent talks today by @EndoDocsRock and @miya_mck at the 26th annual @wakeforestmed Diabetes Management Conference 👏 #WakeEndo @AtriumHealthWFB
Great news for those with iPhones and on Omnipod
🚨 Breaking News! The Omnipod 5 App for iPhone is now available. Read all the details here: bit.ly/4fiJa9u #Omnipod5 #DiabetesTech
Beautiful day for the #breakthroughT1DNC walk raising awareness and funds for #T1Diabetes @BreakthroughT1D with team #WakeEndo @wakeforestmed @AtriumHealthWFB
Catherine Price, MD, ECNU, FACE retweeted
We showed 1-year glycemic control and safety data of insulin pump naive older adults with #type1diabetes who initiated automated insulin delivery after age 65.
AID systems are for all ages with type 1 diabetes.
pubmed.ncbi.nlm.nih.gov/3937…
Excellent IM grand rounds today on Inpatient DM Management by @ArchanaSadhu at @AtriumHealthWFB @wakeforestmed #WakeEndo
Looking forward to this session on CGM with @josephaloi
Join us for the latest installment in the Hands-On: Tips to Improve Diabetes Care webinar series on October 8th. This one-hour session, "Expanding CGM Use in your Clinical Practice," Register today: professionaleducation.diabet…
Way to go Peds Endo Dr. Walsh at @AtriumHealthWFB @wakeforestmed along with CDCES Paige Johnson and Sarah Rush for upcoming discussion on T2DM in pediatrics. #WakeEndo
Next topic, Management of Pediatric Type 2 Diabetes: A Case Study. Live TODAY, October 1, 1:30-3:00 p.m. ET. Can’t make it, all webinars will be available on-demand. Earn 1.5 free CE credits per webinar. Sign Up Today!
bit.ly/4df0Wci
Exciting study results for those living with #T1Diabetes
Biggest medical discoveries of the week (🧵)
1/10
The world's first autologous stem cell transplant for type 1 diabetes, in a 25-yo woman
After 1 year, she was independent from insulin, with improved blood sugar control
(Study: cell.com/cell/abstract/S0092…)
Another CGM option. Also looking forward to seeing this in the US
Roche to launch new CGM in Europe in ‘coming weeks’ | MedTech Dive
Roche CGM will be using machine learning to detect trends and hypoglycemia at night. Looking forward to seeing in the US #type1diabetes medtechdive.com/news/roche-c…
Catherine Price, MD, ECNU, FACE retweeted
Microplastic pollution is an environmental and public health crisis, with little action being taken. A new @ScienceMagazine review by @ProfRThompson and colleagues is outstanding
science.org/doi/10.1126/scie…
Catherine Price, MD, ECNU, FACE retweeted
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM | Business Wire
One sensor for for year for #type1diabetes businesswire.com/news/home/2…




























